Softwr

Research · head to head

Form Bio vs LabWare

Form Bio logo

Form Bio

Research

Computational platform for cell and gene therapy design and manufacturability

From
On request
Rated
-
LabWare logo

LabWare

Research

Enterprise laboratory information management system for regulated labs

From
On request
Rated
-

The short version

  • Each has a real cost: Form Bio the company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.; LabWare implementation and validation take a year or more, and the services cost frequently exceeds the licence
  • They diverge on capability: Form Bio covers FormManufacturing, LabWare covers Sample management.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Form Bio and LabWare actually diverge.

Attributes where Form Bio and LabWare differ
AttributeForm BioLabWare
PlatformsWeb, CloudWindows, Web, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Form Bio

  • FormManufacturing
  • Payload design optimisation
  • Genome integrity analysis
  • Manufacturability prediction
  • In silico workflows
  • Scale-up monitoring
  • Cell and gene therapy focus
  • Collaboration

Only in LabWare

  • Sample management
  • Instrument integration
  • Regulatory compliance
  • Stability studies
  • ELN
  • Configuration framework

What people use each for

The jobs each tool is most often brought in to do.

Form Bio

  • A gene therapy developer discovering manufacturability problems with an AAV construct late in process development and wanting to move that analysis earliernot LabWare
  • A biotech comparing several candidate payload designs in silico before committing to expensive production runsnot LabWare
  • A CDMO characterising what a client construct actually produces against what was specifiednot LabWare
  • A programme team needing genome integrity evidence to support regulatory conversations about product consistencynot LabWare

LabWare

  • Pharmaceutical quality control laboratories subject to regulatory inspectionnot Form Bio
  • Multi-site laboratory networks needing one method and specification librarynot Form Bio
  • Contract laboratories managing chain of custody across many clientsnot Form Bio
  • Laboratories replacing a validated legacy LIMS they can no longer maintainnot Form Bio

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Form Bio

  • The company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.
  • The current offering launched AAV-focused, so developers working in lentiviral, mRNA or cell therapy modalities are outside the scope the platform was built and validated for.
  • No pricing is published and engagements are scoped per programme, which makes it impossible to size the commitment before entering a sales process.
  • This is a young venture-funded company whose analyses feed regulatory-facing decisions, so continuity of the vendor over a multi-year development programme is a genuine diligence question rather than a formality.
  • Predictive manufacturability models need real production data to be trustworthy, and the value depends on how much of that a young vendor has accumulated, which is difficult for a buyer to verify independently.

LabWare

  • Implementation and validation take a year or more, and the services cost frequently exceeds the licence
  • Pricing is entirely quote-based with no public reference point, even by enterprise standards
  • Extensive configuration means the finished system depends heavily on implementation quality, and outcomes vary widely between customers
  • The interface is functional rather than modern, which is a common objection from scientists used to consumer software
  • Substantially over-specified for research laboratories without regulatory obligations

Pricing, plan by plan

Form Bio

On request
  • FormManufacturing$undefined/year
    • Pricing only through a sales process
    • Scoped per therapeutic programme rather than per seat
    • AAV-focused offering at launch

LabWare

On request
  • LabWare LIMS$undefined/year
    • Sample management
    • Instrument integration
    • Regulatory compliance

Which should you pick?

Choose Form Bio if

  • You need formmanufacturing.
  • You work on Web, Cloud.
  • You also want payload design optimisation.

Choose LabWare if

  • You need sample management.
  • You work on Windows, Web, Cloud, On-premise.
  • You also want instrument integration.

Questions people ask

Is Form Bio or LabWare better?
Neither clearly leads. Form Bio starts at On request and LabWare at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Form Bio or LabWare?
Form Bio starts at On request and LabWare at On request.
Does Form Bio or LabWare run on more platforms?
Form Bio runs on Web, Cloud. LabWare runs on Windows, Web, Cloud, On-premise.
What is Form Bio best used for?
Form Bio is most often used for a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier, a biotech comparing several candidate payload designs in silico before committing to expensive production runs, a cdmo characterising what a client construct actually produces against what was specified, a programme team needing genome integrity evidence to support regulatory conversations about product consistency. Of those, a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier and a biotech comparing several candidate payload designs in silico before committing to expensive production runs are not what LabWare is typically brought in for.
What can Form Bio do that LabWare cannot?
Form Bio covers FormManufacturing, Payload design optimisation, Genome integrity analysis, Manufacturability prediction. LabWare covers Sample management, Instrument integration, Regulatory compliance, Stability studies.

Answered from the vendors’ own pages

Form Bio: What does Form Bio sell now?

FormManufacturing, launched in 2026, an AAV-focused platform for predicting, optimising and monitoring manufacturability of genetic medicines from construct design through scale-up.

LabWare: Why is LabWare so dominant in pharma?

Validation experience. In a regulated laboratory the software forms part of what an inspector examines, and decades of accumulated validation practice is not something a newer vendor can substitute for.

Form Bio: Is it still a general bioinformatics platform?

No. It has narrowed from broad computational life sciences tooling to cell and gene therapy, and within that to AAV.

LabWare: What does it cost?

Not published. Enterprise licensing plus implementation and validation services, and the services frequently exceed the licence.

Form Bio: Where did the company come from?

It spun out of Colossal Biosciences in 2022.

LabWare: How long is implementation?

A year or more for a regulated laboratory, including validation. Anyone quoting substantially less is either scoping narrowly or omitting validation.

Form Bio: Is pricing published?

No. Engagements are scoped per programme through a sales process.

LabWare: Does it include an electronic laboratory notebook?

Yes, LabWare offers ELN alongside LIMS on the same platform, which avoids the integration problem of running two vendors.

LabWare: Is it suitable for a research lab?

Usually not. Research laboratories without regulatory obligations pay for compliance machinery they do not need, and Benchling or a lighter LIMS fits better.

Share

Related pages

Other head to heads